| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 09/02/2010 | US20100221358 Synthetic derivatives beta glycolipids and compositions thereof for the treatment of pathologic disorders |
| 09/02/2010 | US20100221357 Drug delivery product and methods |
| 09/02/2010 | US20100221348 Therapeutic uses of dunaliella powder |
| 09/02/2010 | US20100221347 Enhancing solute transport within a tissue scaffold |
| 09/02/2010 | US20100221340 Method and compositions for treatment or prevention of inflammatory conditions |
| 09/02/2010 | US20100221335 Sustained-release preparation and method for producing the same |
| 09/02/2010 | US20100221331 Pharmaceutical compositions comprising colloidal silicon dioxide |
| 09/02/2010 | US20100221330 Buoyant formulations of betaine |
| 09/02/2010 | US20100221326 Pharmaceutical compositions for oral use for treating patients affected by obesity |
| 09/02/2010 | US20100221321 Apparatus And Methods For Delivering A Plurality Of Medicaments For Management Of Co-Morbid Diseases, Illnesses Or Conditions |
| 09/02/2010 | US20100221317 Dynamin mediated diseases and associated methods and products |
| 09/02/2010 | US20100221305 Formulations for coated microprojections containing non-volatile counterions |
| 09/02/2010 | US20100221298 Novel galenical system for active transport, method for preparation and use |
| 09/02/2010 | US20100221259 Nitrogen-containing heterocyclic compounds and medicinal use thereof |
| 09/02/2010 | US20100221258 Method of treating a pathological syndrome and a pharmaceutical agent |
| 09/02/2010 | US20100221257 Binding members-513 |
| 09/02/2010 | US20100221255 Apelin peptides and methods of use |
| 09/02/2010 | US20100221240 Chemically Modified Peptide Analogs |
| 09/02/2010 | US20100221221 N-phenyl-2-pyrimidineamine derivatives |
| 09/02/2010 | US20100221210 Dimeric Alpha Interferon PEGylated Site-Specifically Shows Enhanced and Prolonged Efficacy in Vivo |
| 09/02/2010 | US20100221179 IL-1 Binding Proteins |
| 09/02/2010 | CA2753499A1 A drug identification protocol for type 2 diabetes based on gene expression signatures |
| 09/02/2010 | CA2753316A1 Magnesium oxide granules |
| 09/02/2010 | CA2751279A1 Novel dioxo-imidazolidine derivatives, which inhibit the enzyme soat-1, pharmaceutical and cosmetic compositions containing them |
| 09/01/2010 | EP2223938A1 Derivatives of exendin |
| 09/01/2010 | EP2223922A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 09/01/2010 | EP2223914A1 Tricyclic condensed pyrazole derivatives as CB1 inhibitors |
| 09/01/2010 | EP2223697A1 Lactic acid bacterium-containing preparation |
| 09/01/2010 | EP2222673A1 Octahydroquinoli zines for antidiabetic treatment |
| 09/01/2010 | EP2222645A2 Benzimidazole derivatives and their use as fxr agonists |
| 09/01/2010 | EP2222304A2 Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| 09/01/2010 | EP2222302A1 A method for treating over-eating disorders |
| 09/01/2010 | EP2102215B1 4,5,6,7-tetrahydro-thieno [2,3-c]pyridines as h3 modulators |
| 09/01/2010 | EP2004657B1 Condensed imidazole derivatives as aldosterone synthase inhibitors |
| 09/01/2010 | EP1979322B1 Cyclohexyl sulfonamide derivatives having h3 receptor activity |
| 09/01/2010 | EP1845092B1 Pyrimidinone compounds, their preparation and use thereof |
| 09/01/2010 | EP1838698B1 Pyrimidine derivatives as gpcr agonists |
| 09/01/2010 | EP1751126B1 Alkyl carbamate-substituted butyrolactones serving as lipase inhibitors |
| 09/01/2010 | EP1430027B1 Novel aminoazetidine, -pyrrolidine and -piperidine derivatives |
| 09/01/2010 | EP1423406B1 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina) |
| 09/01/2010 | EP1337558B1 A "bach" g protein coupled receptor polypeptide and polynucleotide encoding this receptor |
| 09/01/2010 | CN1994123B Health biscuit series containing astragalus root for diabetic patients and preparation process thereof |
| 09/01/2010 | CN1978445B Compound serving as human-derived adenoside mononucleoside activated protein kinase activator, and its preparing method and use |
| 09/01/2010 | CN1969855B Pharmaceutical composition having target organ protection function and usage thereof |
| 09/01/2010 | CN1947794B Medicine composition containing sulfonylurea compounds and phenoxy acid type compounds |
| 09/01/2010 | CN1938018B Use of compounds for the preparation of a therapeutical composition for treatment of various disease states associated with a reduced igf-1 serum level |
| 09/01/2010 | CN101821266A Modulators of cystic fibrosis transmembrane conductance regulator |
| 09/01/2010 | CN101821264A Pyridine derivatives useful as glucokinase activators |
| 09/01/2010 | CN101821240A N- ( pyrazole- 3 -yl) -benzamide derivatives as glucokinase activators |
| 09/01/2010 | CN101821236A Five-membered heterocyclic compound |
| 09/01/2010 | CN101821234A Phenoxy-pyrrolidine derivative and its use and compositions |
| 09/01/2010 | CN101820871A Rapid-acting, blood-arginine-level-increasable oral preparation comprising citrulline and arginine |
| 09/01/2010 | CN101820777A Foodstuff comprising extract of plant of the genus salacia and flavonoid |
| 09/01/2010 | CN101818133A VSIG4 (V-set and Ig domain containing 4) and IGRP (glucose-6-phosphatase catalytic subunit-related protein) dual-gene coexpression recombinant adenovirus as well as preparation method and application thereof |
| 09/01/2010 | CN101817940A Heparin-derived polysaccharide mixtures, preparation thereof and pharmaceutical compositions containing same |
| 09/01/2010 | CN101817932A Polyamido-amine dendrimers -modified macroporous crosslinked chitosan microsphere and preparation method thereof |
| 09/01/2010 | CN101817885A Method for preparing organic calcium supplement by using radix codonopsitis |
| 09/01/2010 | CN101817884A Method for extracting narrow-leaved oleaster polysaccharide |
| 09/01/2010 | CN101817878A Monomer quick-acting insulin as well as preparing method and application thereof |
| 09/01/2010 | CN101817862A Ursolic acid-3-O-beta-D-pyranglucuronide and derivatives thereof, and preparation method and medicinal application thereof |
| 09/01/2010 | CN101817861A Method for preparing high-purity astragaloside for treating diabetes nephropathy and peripheral neuritis of diabetes complications |
| 09/01/2010 | CN101817833A DPP-IV inhibitor |
| 09/01/2010 | CN101817805A Andrographolide derivative and preparation method and application thereof |
| 09/01/2010 | CN101816778A Whey protein pre-load |
| 09/01/2010 | CN101816770A Chinese medicinal composition for treating diabetes and preparation method thereof |
| 09/01/2010 | CN101816744A Energy-saving and environmentally-friendly method for preparing garlic oil cyclodextrine inclusion compound |
| 09/01/2010 | CN101816738A Anti-fatigue nutrient health-care wine for improving male sexual function and preparation method thereof |
| 09/01/2010 | CN101816719A Peach blossom or peach leaf general flavone and application thereof in preparing medicines or health care products for lowering blood sugar and fat and preventing and/or treating diabetes and complications |
| 09/01/2010 | CN101816717A Substituted tea for reducing blood sugar and manufacturing method thereof |
| 09/01/2010 | CN101816699A Substituted tea for reducing blood pressure and blood fat and manufacturing method thereof |
| 09/01/2010 | CN101816698A Composition for preventing and curing metabolism disturbance syndrome |
| 09/01/2010 | CN101816697A Method for preparing organic iron supplement by using radix codonopsitis |
| 09/01/2010 | CN101816692A Extraction method of chrysanthemum saponin |
| 09/01/2010 | CN101816675A Chitosan composition with fat-reducing effect and applications thereof |
| 09/01/2010 | CN101816674A Hepcidin inhibitor and application thereof |
| 09/01/2010 | CN101816657A Process for preparing vinegar powder soft capsules |
| 09/01/2010 | CN101816656A Formula of vinegar powder soft capsules |
| 09/01/2010 | CN101816655A Medicinal preparation containing repaglinide and ligustrazine and application thereof in diabetic complications |
| 09/01/2010 | CN101816415A Nutrition-balancing and immunity-enhancing natural green algae tablets and production method thereof |
| 09/01/2010 | CN101297672B Method for producing active peptides from enzymolysis of fish proteins using active enzymes in angleworm intestinal canal |
| 09/01/2010 | CN101234160B Fat-reducing and liver-protecting Chinese medicine preparation and preparation thereof |
| 09/01/2010 | CN101229233B Chinese traditional medicine preparation for antiatheroscloresis and liver-protection, and preparingng method thereof |
| 09/01/2010 | CN101057678B Composition containing natural plant extraction or monomer |
| 08/31/2010 | US7786352 Methods for the production of apolipoproteins in transgenic plants |
| 08/31/2010 | US7786311 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators |
| 08/31/2010 | US7786177 Phenylalanine enamide derivatives |
| 08/31/2010 | US7786174 Administering a compound that inhibits islet amyloid polypeptide-associated amyloid deposition, e.g., 8-hydroxy-5-quinolinesulfonic acid, sodium cyclohexylsulfamate, or octahydroisoquinolinyl-N-propanesulfonic acid; antidiabetic agents |
| 08/31/2010 | US7786165 Antidiabetic agents; obesity; insulin resistance; neurodegenerative diseases; Alzheimer's disease |
| 08/31/2010 | US7786135 Substituted pyrroline kinase inhibitors |
| 08/31/2010 | US7786108 Compounds and method for treating dyslipidemia |
| 08/31/2010 | US7786102 Steroids as agonists for FXR |
| 08/31/2010 | US7786077 Insulins combinations |
| 08/31/2010 | US7785886 Contacting ABC1-expressing cells with a composition containing test compound and measuring biological activity by determining the level of efflux of labeled substrate ; use in treating cardiovascular disease |
| 08/31/2010 | US7785819 Diagnosis of autoimmune disease; generate solid support, incubate with fluid sample, detect preferential antigens, compare to control, evaluate for autoimmune diseases |
| 08/31/2010 | US7785620 Cholesterol lowering and blood lipids lowering composition |
| 08/31/2010 | US7785599 Albumin fusion proteins |
| 08/31/2010 | US7785567 treatment of hypercholesterolemia or cardiovascular disease associated with atherosclerosis by administration of Growth Hormone Releasing Peptides to patient; reducing blood plasma cholesterol levels; modulating expression of scavenger receptor CD36 and genes involved in cellular cholesterol efflux |
| 08/26/2010 | WO2010096813A1 Krüppel-like factors and fat regulation |
| 08/26/2010 | WO2010096125A1 Methods and kits for treating disease by administering insulin-like growth factor binding protein-2 |
| 08/26/2010 | WO2010095808A2 Production method for astragalus membranaceus extract employing enzymolysis, and a composition for preventing or alleviating diabetes or obesity containing an active ingredient comprising an astragalus membranaceus extract produced by means of the production method |